Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network-Reference-Cited by-同舟云学术

Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network

Published:2012-02 Issue:1-2 Volume:243 Page:73-80
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Muls Nathalie,Jnaoui Karima,Dang Hong Anh,Wauters Antony,Van Snick Jacques,Sindic Christian Jean-Marie,van Pesch Vincent

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference52 articles.

1. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells;Acosta-Rodriguez;Nat. Immunol.,2007

2. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) — a Europe against cancer program;Beillard;Leukemia,2003

3. TGF-beta induces IL-9 production from human Th17 cells;Beriou;J. Immunol.,2010

4. Induction and effector functions of T(H)17 cells;Bettelli;Nature,2008

5. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis;Bielekova;J. Immunol.,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Effect of Calcitriol on Experimental Autoimmune Encephalomyelitis Mice, A Multiple Sclerosis Animal Model;Iranian Journal of Allergy, Asthma and Immunology;2023-11-07

2. Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review);Medicine International;2023-08-17

3. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis;Neurological Sciences;2019-11-14

4. Decreased plasma levels of 25(OH)D in multiple sclerosis patients. Correlation with disease severity expressed by EDSS, MSSS, progression index and Herbert´s scale severity grade;Bratislava Medical Journal;2019

5. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis;European Journal of Immunology;2018-09-25